1. Feest TG,
Rajamahesh J, Byrne C, Ahmad A, Ansell D,
Burden R, et al. Trends in adult renal
replacement therapy in the UK: 1982-2002.
QJM. 2005;98:21-8.
https://doi.org/10.1093/qjmed/hci007
PMid:15625350
|
|
2. van Dijk PC,
Jager KJ, de Charro F, Collart F, Cornet
R, Dekker FW, et al; ERA-EDTA registry.
Renal replacement therapy in Europe: the
results of a collaborative effort by the
ERA-EDTA registry and six national or
regional registries. Nephrol
Dial Transplant. 2001;16:1120-9.
https://doi.org/10.1093/ndt/16.6.1120
PMid:11390709
|
|
|
3. Mallick NP,
Gokal R. Haemodialysis. Lancet. 1999;353:737-42.
https://doi.org/10.1016/S0140-6736(97)09411-7
PMid:10073530
|
|
|
4. Tomas I,
Marinho JS, Limeres J, Santos MJ, Araujo
L, Diz P. Changes in salivary composition
in patients with renal failure. Arch
Oral Biol. 2008;53:528-32.
https://doi.org/10.1016/j.archoralbio.2008.01.006
PMid:18294611
|
|
|
5. Kho HS, Lee
SW, Chung SC, Kim YK. Oral manifestations
and salivary flow rate, pH and buffer
capacity in patients with end-stage renal
disease undergoing hemodialysis. Oral
surg oral med oral pathol oral radiol
endod. 1999;88:316-9.
https://doi.org/10.1016/S1079-2104(99)70035-1
PMid:10503861
|
|
|
6. Klassen JT,
Krasko BM. The dental health status of
dialysis patients. J
Can Dent Assoc. 2002;68:34-8.
PMid:11844416
|
|
|
7. Bots CP,
Brand HS, Poorterman JHG, van Amerongen
BM, Valentijn-Benz M, Veerman ECI, et al.
Oral and salivary changes in patients
with end stage renal disease (ESRD): a
two year follow-up study. Br
Dent J. 2007;202:1-5.
https://doi.org/10.1038/bdj.2007.47
PMid:17235362
|
|
|
8. Martins C,
Siqueria WL, de Oliveira E, de Souza
Guimaraes Primo LS, Nicolau J. Salivary
analysis of patients with chronic renal
failure undergoing hemodialysis. Spec
Care Dentist. 2006;26:205-8.
https://doi.org/10.1111/j.1754-4505.2006.tb01439.x
PMid:17249441
|
|
|
9. Kaushik A,
Reddy SS, Umesh L, Devi BKY, Santana N,
Rakesh N. Oral and salivary changes among
renal patients undergoing hemodialysis: A
cross-sectional study. Indian
J Nephrol. 2013;23:125-9.
https://doi.org/10.4103/0971-4065.109421
PMid:23716919 PMCid:PMC3658290
|
|
|
10. Bayraktar G,
Kurtulus I, Kazancioglu R, Bayramgurler
I, Cintan S, Bural C, et al. Oral health
and inflammation in patients with
end-stage renal failure. Perit
Dial Int 2009;29:472-9.
PMid:19602614
|
|
|
11. Al-Nowaiser
A, Roberts GJ, Trompeter RS, Wilson M,
Lucas VS. Oral health in children with
chronic renal failure. Pediatr
Nephrol. 2003;18:39-45.
https://doi.org/10.1007/s00467-002-0999-7
PMid:12488989
|
|
|
12.
Seethalakshmi C, Koteeswaran D,
Chiranjeevi V. Correlation of Serum and
Salivary Biochemical Parameters in End
Stage Renal Disease Patients Undergoing
Hemodialysis in Pre and Post-Dialysis
State. J
Clin Diagn Res. 2014;8:12-4.
PMid:
25653941 PMCid: PMC4316247
|
|
|
13. Venkatapathy
R, Govindarajan V, Oza N, Parameswaran S.
Salivary Creatinine Estimation as an
Alternative to Serum Creatinine in
Chronic Kidney Disease Patients. Int
J Nephrol. 2014;2014:742724.
https://doi.org/10.1155/2014/742724
PMid:24818023 PMCid:PMC4003770
|
|
|
14.
Walt DR, Blicharz TM, Hayman RB, Rissin DM,
Bowden M, Siqueira WL, et al. Microsensor
arrays for saliva diagnostics. Ann N Y
Acad Sci. 2007;1098:389-400.
https://doi.org/10.1196/annals.1384.031
PMid:17435144
|
|
|
15. Blicharz TM,
Rissin DM, Bowden M, Hayman RB, DiCesare
C, Bhatia JS, et al. Use of colorimetric
test strips for monitoring the effect of
hemodialysis on salivary nitrite and uric
acid in patients with end-stage renal
disease: a proof of principle. Clin
Chem. 2008;54:1473-80.
https://doi.org/10.1373/clinchem.2008.105320
PMid:18676588 PMCid:PMC2710817
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|